Literature DB >> 29997211

Nup153 Unlocks the Nuclear Pore Complex for HIV-1 Nuclear Translocation in Nondividing Cells.

Cindy Buffone1, Alicia Martinez-Lopez1, Thomas Fricke1, Silvana Opp1, Marco Severgnini2, Ingrid Cifola2, Luca Petiti2, Stella Frabetti3, Katarzyna Skorupka4, Kaneil K Zadrozny4, Barbie K Ganser-Pornillos4, Owen Pornillos4, Francesca Di Nunzio5, Felipe Diaz-Griffero6.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) displays the unique ability to infect nondividing cells. The capsid of HIV-1 is the viral determinant for viral nuclear import. To understand the cellular factors involved in the ability of HIV-1 to infect nondividing cells, we sought to find capsid mutations that allow the virus to infect dividing but not nondividing cells. Because the interaction of capsid with the nucleoporin protein 153 (Nup153) is important for nuclear import of HIV-1, we solved new crystal structures of hexameric HIV-1 capsid in complex with a Nup153-derived peptide containing a phenylalanine-glycine repeat (FG repeat), which we used to guide structure-based mutagenesis of the capsid-binding interface. HIV-1 viruses with mutations in these capsid residues were tested for their ability to infect dividing and nondividing cells. HIV-1 viruses with capsid N57 substitutions infected dividing but not nondividing cells. Interestingly, HIV-1 viruses with N57 mutations underwent reverse transcription but not nuclear translocation. The mutant capsids also lost the ability to interact with Nup153 and CPSF6. The use of small molecules PF74 and BI-2 prevented the interaction of FG-containing nucleoporins (Nups), such as Nup153, with the HIV-1 core. Analysis of integration sites in HIV-1 viruses with N57 mutations revealed diminished integration into transcriptionally active genes in a manner resembling that of HIV-1 in CPSF6 knockout cells or that of HIV-1-N74D. The integration pattern of the N57 mutant HIV-1 can be explained by loss of capsid interaction with CPSF6, whereas capsid interaction with Nup153 is required for HIV-1 to infect nondividing cells. Additionally, the observed viral integration profiles suggested that integration site selection is a multiparameter process that depends upon nuclear factors and the state of the cellular chromatin.IMPORTANCE One of the key advantages that distinguish lentiviruses, such as HIV-1, from all other retroviruses is its ability to infect nondividing cells. Interaction of the HIV-1 capsid with Nup153 and CPSF6 is important for nuclear entry and integration; however, the contribution of each of these proteins to nuclear import and integration is not clear. Using genetics, we demonstrated that these proteins contribute to different processes: Nup153 is essential for the HIV-1 nuclear import in nondividing cells, and CPSF6 is important for HIV-1 integration. In addition, nuclear factors such as CPSF6 and the state of the chromatin are known to be important for integration site selection; nevertheless, the preferential determinant influencing integration site selection is not known. This work demonstrates that integration site selection is a multiparameter process that depends upon nuclear factors and the state of the cellular chromatin.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  CPSF6; HIV integration; HIV nuclear import; HIV-1; NPC; Nup153; capsid binding; integration; nondividing cells; nuclear import

Mesh:

Substances:

Year:  2018        PMID: 29997211      PMCID: PMC6146805          DOI: 10.1128/JVI.00648-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication.

Authors:  Zhujun Ao; Kallesh Danappa Jayappa; Binchen Wang; Yingfeng Zheng; Sam Kung; Eric Rassart; Reinhard Depping; Matthias Kohler; Eric A Cohen; Xiaojian Yao
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

3.  HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism.

Authors:  Anna C Hearps; David A Jans
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

4.  Structural basis of HIV-1 capsid recognition by PF74 and CPSF6.

Authors:  Akash Bhattacharya; Steven L Alam; Thomas Fricke; Kaneil Zadrozny; Jaroslaw Sedzicki; Alexander B Taylor; Borries Demeler; Owen Pornillos; Barbie K Ganser-Pornillos; Felipe Diaz-Griffero; Dmitri N Ivanov; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-17       Impact factor: 11.205

5.  Optimized THP-1 differentiation is required for the detection of responses to weak stimuli.

Authors:  E K Park; H S Jung; H I Yang; M C Yoo; C Kim; K S Kim
Journal:  Inflamm Res       Date:  2007-01       Impact factor: 4.575

6.  Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor.

Authors:  Fabrice Michel; Corinne Crucifix; Florence Granger; Sylvia Eiler; Jean-François Mouscadet; Sergei Korolev; Julia Agapkina; Rustam Ziganshin; Marina Gottikh; Alexis Nazabal; Stéphane Emiliani; Richard Benarous; Dino Moras; Patrick Schultz; Marc Ruff
Journal:  EMBO J       Date:  2009-02-19       Impact factor: 11.598

7.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.

Authors:  Jan De Rijck; Christine de Kogel; Jonas Demeulemeester; Sofie Vets; Sara El Ashkar; Nirav Malani; Frederic D Bushman; Bart Landuyt; Steven J Husson; Katrien Busschots; Rik Gijsbers; Zeger Debyser
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

8.  Integration of murine leukemia virus DNA depends on mitosis.

Authors:  T Roe; T C Reynolds; G Yu; P O Brown
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

9.  Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells.

Authors:  Masahiro Yamashita; Omar Perez; Thomas J Hope; Michael Emerman
Journal:  PLoS Pathog       Date:  2007-10-26       Impact factor: 6.823

10.  LEDGF/p75 interacts with mRNA splicing factors and targets HIV-1 integration to highly spliced genes.

Authors:  Parmit Kumar Singh; Matthew R Plumb; Andrea L Ferris; James R Iben; Xiaolin Wu; Hind J Fadel; Brian T Luke; Caroline Esnault; Eric M Poeschla; Stephen H Hughes; Mamuka Kvaratskhelia; Henry L Levin
Journal:  Genes Dev       Date:  2015-11-01       Impact factor: 11.361

View more
  35 in total

1.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

2.  CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.

Authors:  Douglas K Fischer; Akatsuki Saito; Christopher Kline; Romy Cohen; Simon C Watkins; Masahiro Yamashita; Zandrea Ambrose
Journal:  J Virol       Date:  2019-04-17       Impact factor: 5.103

3.  Cell Type-Dependent Escape of Capsid Inhibitors by Simian Immunodeficiency Virus SIVcpz.

Authors:  Augustin Penda Twizerimana; Rachel Scheck; Daniel Becker; Zeli Zhang; Marianne Wammers; Leandro Avelar; Marc Pflieger; Dieter Häussinger; Thomas Kurz; Holger Gohlke; Carsten Münk
Journal:  J Virol       Date:  2020-11-09       Impact factor: 5.103

4.  Chemical profiling of HIV-1 capsid-targeting antiviral PF74.

Authors:  Lei Wang; Mary C Casey; Sanjeev Kumar V Vernekar; Ha T Do; Rajkumar Lalji Sahani; Karen A Kirby; Haijuan Du; Atsuko Hachiya; Huanchun Zhang; Philip R Tedbury; Jiashu Xie; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2020-05-12       Impact factor: 6.514

Review 5.  Restriction of HIV-1 and other retroviruses by TRIM5.

Authors:  Barbie K Ganser-Pornillos; Owen Pornillos
Journal:  Nat Rev Microbiol       Date:  2019-07-16       Impact factor: 60.633

6.  Novel HIV-1 capsid-targeting small molecules of the PF74 binding site.

Authors:  Lei Wang; Mary C Casey; Sanjeev Kumar V Vernekar; Rajkumar Lalji Sahani; Jayakanth Kankanala; Karen A Kirby; Haijuan Du; Atsuko Hachiya; Huanchun Zhang; Philip R Tedbury; Jiashu Xie; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Eur J Med Chem       Date:  2020-07-19       Impact factor: 6.514

7.  Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability.

Authors:  Lei Wang; Mary C Casey; Sanjeev Kumar V Vernekar; Rajkumar Lalji Sahani; Karen A Kirby; Haijuan Du; Huanchun Zhang; Philip R Tedbury; Jiashu Xie; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Acta Pharm Sin B       Date:  2020-07-31       Impact factor: 11.413

8.  Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.

Authors:  Anastasia Selyutina; Mirjana Persaud; Lacy M Simons; Angel Bulnes-Ramos; Cindy Buffone; Alicia Martinez-Lopez; Viviana Scoca; Francesca Di Nunzio; Joseph Hiatt; Alexander Marson; Nevan J Krogan; Judd F Hultquist; Felipe Diaz-Griffero
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

Review 9.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12

Review 10.  The Viral Capsid: A Master Key to Access the Host Nucleus.

Authors:  Guillermo Blanco-Rodriguez; Francesca Di Nunzio
Journal:  Viruses       Date:  2021-06-20       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.